Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 566

1.

MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.

Zhang JP, Zeng C, Xu L, Gong J, Fang JH, Zhuang SM.

Oncogene. 2014 Jul 31;33(31):4069-76. doi: 10.1038/onc.2013.369. Epub 2013 Sep 9.

PMID:
24013226
2.

MicroRNA-30b Suppresses Epithelial-Mesenchymal Transition and Metastasis of Hepatoma Cells.

Sun X, Zhao S, Li H, Chang H, Huang Z, Ding Z, Dong L, Chen J, Zang Y, Zhang J.

J Cell Physiol. 2017 Mar;232(3):625-634. doi: 10.1002/jcp.25466. Epub 2016 Jun 30.

PMID:
27333771
3.

MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.

Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB.

Oncotarget. 2015 Jul 30;6(21):18613-30.

4.

FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.

Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.

World J Gastroenterol. 2015 Jan 7;21(1):196-213. doi: 10.3748/wjg.v21.i1.196.

5.

Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.

Yan H, Dong X, Zhong X, Ye J, Zhou Y, Yang X, Shen J, Zhang J.

Mol Carcinog. 2014 Dec;53(12):960-9. doi: 10.1002/mc.22064. Epub 2013 Jul 17.

PMID:
23861222
6.

MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets.

Chen SP, Liu BX, Xu J, Pei XF, Liao YJ, Yuan F, Zheng F.

BMC Cancer. 2015 Oct 15;15:706. doi: 10.1186/s12885-015-1738-3.

7.

MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA.

Wang SC, Lin XL, Li J, Zhang TT, Wang HY, Shi JW, Yang S, Zhao WT, Xie RY, Wei F, Qin YJ, Chen L, Yang J, Yao KT, Xiao D.

PLoS One. 2014 Jul 3;9(7):e101330. doi: 10.1371/journal.pone.0101330. eCollection 2014.

8.

miR-153 inhibits epithelial-to-mesenchymal transition in hepatocellular carcinoma by targeting Snail.

Xia W, Ma X, Li X, Dong H, Yi J, Zeng W, Yang Z.

Oncol Rep. 2015 Aug;34(2):655-62. doi: 10.3892/or.2015.4008. Epub 2015 May 28.

PMID:
26035427
9.

MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.

Shen G, Lin Y, Yang X, Zhang J, Xu Z, Jia H.

BMC Cancer. 2014 Jun 2;14:393. doi: 10.1186/1471-2407-14-393.

10.

MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.

Huang N, Wu Z, Lin L, Zhou M, Wang L, Ma H, Xia J, Bin J, Liao Y, Liao W.

Oncotarget. 2015 Jun 20;6(17):15222-34.

11.

microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition.

Wang SH, Li X, Zhou LS, Cao ZW, Shi C, Zhou CZ, Wen YG, Shen Y, Li JK.

Tumour Biol. 2013 Dec;34(6):3705-12. doi: 10.1007/s13277-013-0954-1. Epub 2013 Jul 20.

PMID:
23873106
12.

Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis.

Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X, Zhu Z, Jiao H, Lin J, Jiang K, Ding L, Zhang H, Cheng L, Fu H, Song Y, Jiang Y, Liu J, Wang R, Du N, Ye Q.

J Clin Invest. 2013 Feb;123(2):630-45. doi: 10.1172/JCI64265. Epub 2013 Jan 16.

13.

Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.

Wu WL, Wang WY, Yao WQ, Li GD.

Int J Mol Med. 2015 Dec;36(6):1713-9. doi: 10.3892/ijmm.2015.2379. Epub 2015 Oct 16.

PMID:
26499886
14.

MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.

Zhou JN, Zeng Q, Wang HY, Zhang B, Li ST, Nan X, Cao N, Fu CJ, Yan XL, Jia YL, Wang JX, Zhao AH, Li ZW, Li YH, Xie XY, Zhang XM, Dong Y, Xu YC, He LJ, Yue W, Pei XT.

Hepatology. 2015 Sep;62(3):801-15. doi: 10.1002/hep.27887. Epub 2015 Jul 3.

PMID:
25953743
15.

MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.

Ma DN, Chai ZT, Zhu XD, Zhang N, Zhan DH, Ye BG, Wang CH, Qin CD, Zhao YM, Zhu WP, Cao MQ, Gao DM, Sun HC, Tang ZY.

J Hematol Oncol. 2016 Jan 6;9:1. doi: 10.1186/s13045-015-0229-y.

16.

MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.

Wang W, Lin H, Zhou L, Zhu Q, Gao S, Xie H, Liu Z, Xu Z, Wei J, Huang X, Zheng S.

Eur J Surg Oncol. 2014 Nov;40(11):1586-94. doi: 10.1016/j.ejso.2013.11.008. Epub 2013 Nov 19.

PMID:
24290372
17.

miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.

Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang Y, Gu Q, Dong X, Liu F, Zhang Y, Li X.

Sci Rep. 2016 Mar 16;6:23091. doi: 10.1038/srep23091.

18.

CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.

Zhou SL, Zhou ZJ, Hu ZQ, Li X, Huang XW, Wang Z, Fan J, Dai Z, Zhou J.

Cancer Lett. 2015 Mar 28;358(2):124-35. doi: 10.1016/j.canlet.2014.11.044. Epub 2014 Nov 24.

PMID:
25462858
19.

Downregulation of miRNA-30c and miR-203a is associated with hepatitis C virus core protein-induced epithelial-mesenchymal transition in normal hepatocytes and hepatocellular carcinoma cells.

Liu D, Wu J, Liu M, Yin H, He J, Zhang B.

Biochem Biophys Res Commun. 2015 Sep 4;464(4):1215-21. doi: 10.1016/j.bbrc.2015.07.107. Epub 2015 Jul 23.

PMID:
26210453
20.

MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.

Chen JS, Li HS, Huang JQ, Dong SH, Huang ZJ, Yi W, Zhan GF, Feng JT, Sun JC, Huang XH.

Cancer Lett. 2016 May 28;375(1):73-83. doi: 10.1016/j.canlet.2016.02.043. Epub 2016 Mar 2.

PMID:
26944318

Supplemental Content

Support Center